TY - STD TI - AVERT. Global HIV and AIDS statistics. 2017. https://www.avert.org/global-hiv-and-aids-statistics. UR - https://www.avert.org/global-hiv-and-aids-statistics ID - ref1 ER - TY - STD TI - U.S. Department of Health and Human Services. FDA approval of HIV medicines; 2016. ID - ref2 ER - TY - STD TI - U.S. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents; 2016. ID - ref3 ER - TY - JOUR PY - 2006 DA - 2006// TI - Evolution of HIV/AIDS prevention programs–United States, 1981–2006 JO - MMWR Morb Mortal Wkly Rep VL - 55 ID - ref4 ER - TY - JOUR AU - Sepkowitz, K. A. PY - 2001 DA - 2001// TI - AIDS-the first 20 years JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200106073442306 DO - 10.1056/NEJM200106073442306 ID - Sepkowitz2001 ER - TY - BOOK PY - 2016 DA - 2016// TI - Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection PB - World Health Organization CY - Geneva ID - ref6 ER - TY - BOOK PY - 2003 DA - 2003// TI - Adherence to long-term therapies: evidence for action PB - World Health Organization CY - Geneva ID - ref7 ER - TY - JOUR AU - Deeks, S. G. AU - Lewin, S. R. AU - Havlir, D. V. PY - 2013 DA - 2013// TI - The end of AIDS: hIV infection as a chronic disease JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)61809-7 DO - 10.1016/S0140-6736(13)61809-7 ID - Deeks2013 ER - TY - STD TI - UNAIDS. Treatment 2015; 2015. ID - ref9 ER - TY - STD TI - U.S. Department of Health and Human Services. HIV/AIDS glossary: boosting; 2017. ID - ref10 ER - TY - JOUR AU - Clay, P. G. AU - Nag, S. AU - Graham, C. M. AU - Narayanan, S. PY - 2015 DA - 2015// TI - Meta-analysis of studies comparing single and multi-tablet fixed dose combination HIV treatment regimens JO - Medicine (Baltimore) VL - 94 UR - https://doi.org/10.1097/MD.0000000000001677 DO - 10.1097/MD.0000000000001677 ID - Clay2015 ER - TY - JOUR AU - Moher, D. AU - Shamseer, L. AU - Clarke, M. AU - Ghersi, D. AU - Liberati, A. AU - Petticrew, M. PY - 2015 DA - 2015// TI - Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement JO - Syst Rev VL - 4 UR - https://doi.org/10.1186/2046-4053-4-1 DO - 10.1186/2046-4053-4-1 ID - Moher2015 ER - TY - STD TI - Higgins JPT GS, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration 2008. ID - ref13 ER - TY - STD TI - Critical Appraisal Skills Programme (CASP). 12 questions to help you make sense of cohort study. 2017. ID - ref14 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. PY - 2002 DA - 2002// TI - Quantifying heterogeneity in a meta-analysis JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1186 DO - 10.1002/sim.1186 ID - Higgins2002 ER - TY - JOUR AU - Bangsberg, D. R. AU - Ragland, K. AU - Monk, A. AU - Deeks, S. G. PY - 2010 DA - 2010// TI - A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV + homeless and marginally housed people JO - Aids VL - 24 UR - https://doi.org/10.1097/QAD.0b013e328340a209 DO - 10.1097/QAD.0b013e328340a209 ID - Bangsberg2010 ER - TY - JOUR AU - Fabbiani, M. AU - Zaccarelli, M. AU - Grima, P. AU - Prosperi, M. AU - Fanti, I. AU - Colafigli, M. PY - 2014 DA - 2014// TI - Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naive or switching for simplification HIV-infected patients JO - BMC Infect Dis VL - 14 UR - https://doi.org/10.1186/1471-2334-14-26 DO - 10.1186/1471-2334-14-26 ID - Fabbiani2014 ER - TY - JOUR AU - Skwara, P. AU - Bociaga-Jasik, M. AU - Kalinowska-Nowak, A. PY - 2014 DA - 2014// TI - Adherence to single-tablet versus multiple-tablet regimens in the treatment of HIV infection: a questionnaire-based survey on patients satisfaction JO - HIV AIDS Rev VL - 13 UR - https://doi.org/10.1016/j.hivar.2014.05.001 DO - 10.1016/j.hivar.2014.05.001 ID - Skwara2014 ER - TY - JOUR AU - Sterrantino, G. AU - Santoro, L. AU - Bartolozzi, D. AU - Trotta, M. AU - Zaccarelli, M. PY - 2012 DA - 2012// TI - Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era JO - Patient Prefer Adherence VL - 6 UR - https://doi.org/10.2147/PPA.S31385 DO - 10.2147/PPA.S31385 ID - Sterrantino2012 ER - TY - JOUR AU - Chen, Y. AU - Chen, K. AU - Kalichman, S. C. PY - 2017 DA - 2017// TI - Barriers to HIV medication adherence as a function of regimen simplification JO - Ann Behav Med VL - 51 UR - https://doi.org/10.1007/s12160-016-9827-3 DO - 10.1007/s12160-016-9827-3 ID - Chen2017 ER - TY - JOUR AU - Orkin, C. AU - DeJesus, E. AU - Ramgopal, M. AU - Crofoot, G. AU - Ruane, P. AU - LaMarca, A. PY - 2017 DA - 2017// TI - Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study JO - Lancet HIV VL - 4 UR - https://doi.org/10.1016/S2352-3018(17)30031-0 DO - 10.1016/S2352-3018(17)30031-0 ID - Orkin2017 ER - TY - JOUR AU - Sutton, S. S. AU - Hardin, J. W. AU - Bramley, T. J. AU - D’Souza, A. O. AU - Bennet, C. L. PY - 2016 DA - 2016// TI - Single-versus multiple tablet HIV regimens: adherence and hospitalization risks JO - Am J Manag Care VL - 22 ID - Sutton2016 ER - TY - JOUR AU - Buscher, A. AU - Hartman, C. AU - Kallen, M. A. AU - Giordano, T. P. PY - 2012 DA - 2012// TI - Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients JO - Int J STD AIDS VL - 23 UR - https://doi.org/10.1258/ijsa.2011.011292 DO - 10.1258/ijsa.2011.011292 ID - Buscher2012 ER - TY - JOUR AU - Arribas, J. R. AU - Pialoux, G. AU - Gathe, J. AU - Perri, G. AU - Reynes, J. AU - Tebas, P. PY - 2014 DA - 2014// TI - Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial JO - Lancet Infect Dis VL - 14 UR - https://doi.org/10.1016/S1473-3099(14)70782-0 DO - 10.1016/S1473-3099(14)70782-0 ID - Arribas2014 ER - TY - JOUR AU - Pozniak, A. AU - Markowitz, M. AU - Mills, A. AU - Stellbrink, H. J. AU - Antela, A. AU - Domingo, P. PY - 2014 DA - 2014// TI - Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trial JO - Lancet Infect Dis VL - 14 UR - https://doi.org/10.1016/S1473-3099(14)70796-0 DO - 10.1016/S1473-3099(14)70796-0 ID - Pozniak2014 ER - TY - JOUR AU - Dejesus, E. AU - Young, B. AU - Morales-Ramirez, J. O. AU - Sloan, L. AU - Ward, D. J. AU - Flaherty, J. F. PY - 2009 DA - 2009// TI - Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients JO - J Acquir Immune Defic Syndr VL - 51 UR - https://doi.org/10.1097/QAI.0b013e3181a572cf DO - 10.1097/QAI.0b013e3181a572cf ID - Dejesus2009 ER - TY - JOUR AU - Choi, J. Y. AU - Sungkanuparph, S. AU - Anekthananon, T. AU - Sax, P. AU - DeJesus, E. AU - Edelstein, H. PY - 2016 DA - 2016// TI - Efficacy and safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian subjects with human immunodeficiency virus 1 infection: a sub-analysis of phase 3 clinical trials JO - Infect Chemother VL - 48 UR - https://doi.org/10.3947/ic.2016.48.3.219 DO - 10.3947/ic.2016.48.3.219 ID - Choi2016 ER - TY - STD TI - Rijnders B, Post F, Rieger A. Longer-term renal safety of tenofovir alafenamide vs tenofovir disoproxil fumarate. Conference on retroviruses and opportunistic infections, February 22–25, 2016, Boston 2016. ID - ref29 ER - TY - JOUR AU - Arribas, J. R. AU - Thompson, M. AU - Sax, P. E. AU - Haas, B. AU - McDonald, C. AU - Wohl, A. PY - 2017 DA - 2017// TI - A randomized, double-blind comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), each coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: week 144 results JO - J Acquir Immune Defic Syndr VL - 75 UR - https://doi.org/10.1097/QAI.0000000000001350 DO - 10.1097/QAI.0000000000001350 ID - Arribas2017 ER - TY - JOUR AU - Koenig, E. AU - Orkin, C. AU - Clarke, A. AU - Podzamczer, D. AU - Clotet, B. AU - Callebaut, C. PY - 2016 DA - 2016// TI - Improved safety and efficacy of TAF versus TDF single-tablet regimen in HIV-1 treatment-naïve women through week 48 JO - J Int AIDS Soc VL - 19 ID - Koenig2016 ER - TY - JOUR AU - Palella, F. J. AU - Fisher, M. AU - Tebas, P. AU - Gazzard, B. AU - Ruane, P. AU - Lunzen, J. PY - 2014 DA - 2014// TI - Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants JO - Aids VL - 28 UR - https://doi.org/10.1097/QAD.0000000000000087 DO - 10.1097/QAD.0000000000000087 ID - Palella2014 ER - TY - JOUR AU - Huhn, G. D. AU - Tebas, P. AU - Gallant, J. AU - Wilkin, T. AU - Cheng, A. AU - Yan, M. PY - 2017 DA - 2017// TI - A Randomized, Open-Label trial to evaluate switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in treatment-experienced HIV-1-infected adults JO - J Acquir Immune Defic Syndr VL - 74 UR - https://doi.org/10.1097/QAI.0000000000001193 DO - 10.1097/QAI.0000000000001193 ID - Huhn2017 ER - TY - JOUR AU - Airoldi, M. AU - Zaccarelli, M. AU - Bisi, L. AU - Bini, T. AU - Antinori, A. AU - Mussini, C. PY - 2010 DA - 2010// TI - One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects JO - Patient Prefer Adherence VL - 4 ID - Airoldi2010 ER - TY - JOUR AU - Hanna, D. B. AU - Hessol, N. A. AU - Golub, E. T. AU - Cocohoba, J. M. AU - Cohen, M. H. AU - Levine, A. M. PY - 2014 DA - 2014// TI - Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women JO - J Acquir Immune Defic Syndr VL - 65 UR - https://doi.org/10.1097/QAI.0000000000000082 DO - 10.1097/QAI.0000000000000082 ID - Hanna2014 ER - TY - JOUR AU - Beck, E. J. AU - Mandalia, S. AU - Sangha, R. AU - Youle, M. AU - Brettle, R. AU - Gompels, M. PY - 2012 DA - 2012// TI - Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004–2008 JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0047376 DO - 10.1371/journal.pone.0047376 ID - Beck2012 ER - TY - JOUR AU - Grimes, R. M. AU - Shenouda, T. A. PY - 2013 DA - 2013// TI - Using cost as a consideration for antiretroviral regimen selection: an example using average wholesale prices JO - AIDS Care VL - 25 UR - https://doi.org/10.1080/09540121.2013.766305 DO - 10.1080/09540121.2013.766305 ID - Grimes2013 ER - TY - JOUR AU - Homar, F. AU - Lozano, V. AU - Martinez-Gomez, J. AU - Oyaguez, I. AU - Pareja, A. AU - Payeras, A. PY - 2012 DA - 2012// TI - Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs JO - Health Econ Rev VL - 2 UR - https://doi.org/10.1186/2191-1991-2-16 DO - 10.1186/2191-1991-2-16 ID - Homar2012 ER - TY - JOUR AU - Angeletti, C. AU - Pezzotti, P. AU - Antinori, A. AU - Mammone, A. AU - Navarra, A. AU - Orchi, N. PY - 2014 DA - 2014// TI - Antiretroviral treatment based cost saving interventions may offset expenses for new patients and earlier treatment start JO - HIV Med VL - 15 UR - https://doi.org/10.1111/hiv.12097 DO - 10.1111/hiv.12097 ID - Angeletti2014 ER - TY - JOUR AU - Colombo, G. L. AU - Castagna, A. AU - Matteo, S. AU - Galli, L. AU - Bruno, G. AU - Poli, A. PY - 2014 DA - 2014// TI - Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting JO - Ther Clin Risk Manag VL - 10 ID - Colombo2014 ER - TY - JOUR AU - Colombo, G. L. AU - Matteo, S. AU - Antinori, A. AU - Medaglia, M. AU - Murachelli, S. AU - Rizzardini, G. PY - 2013 DA - 2013// TI - Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines JO - Clinicoecon Outcomes Res VL - 5 UR - https://doi.org/10.2147/CEOR.S48246 DO - 10.2147/CEOR.S48246 ID - Colombo2013 ER - TY - JOUR AU - Colombo, G. L. AU - Matteo, S. AU - Maggiolo, F. PY - 2013 DA - 2013// TI - Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen JO - Clinicoecon Outcomes Res VL - 5 UR - https://doi.org/10.2147/CEOR.S38977 DO - 10.2147/CEOR.S38977 ID - Colombo2013 ER - TY - JOUR AU - Walensky, R. P. AU - Sax, P. E. AU - Nakamura, Y. M. AU - Weinstein, M. C. AU - Pei, P. P. AU - Freedberg, K. A. PY - 2013 DA - 2013// TI - Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States JO - Ann Intern Med VL - 158 UR - https://doi.org/10.7326/0003-4819-158-2-201301150-00002 DO - 10.7326/0003-4819-158-2-201301150-00002 ID - Walensky2013 ER - TY - JOUR AU - Sorbino-Jiménez, C. AU - Jiménez-Nácher, I. AU - Moreno-Ramos, F. PY - 2017 DA - 2017// TI - Analysis of antiretroviral therapy modification in routine clinical practice in the management of HIV infection JO - Eur J Hosp Pharm VL - 24 UR - https://doi.org/10.1136/ejhpharm-2016-000944 DO - 10.1136/ejhpharm-2016-000944 ID - Sorbino-Jiménez2017 ER - TY - JOUR AU - Sweet, D. E. AU - Altice, F. L. AU - Cohen, C. J. AU - Vandewalle, B. PY - 2016 DA - 2016// TI - Cost-effectiveness of single- versus generic multiple-tablet regimens for treatment of HIV-1 infection in the United States JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0147821 DO - 10.1371/journal.pone.0147821 ID - Sweet2016 ER - TY - JOUR AU - Cohen, C. J. AU - Meyers, J. L. AU - Davis, K. L. PY - 2013 DA - 2013// TI - Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV JO - BMJ Open VL - 3 UR - https://doi.org/10.1136/bmjopen-2013-003028 DO - 10.1136/bmjopen-2013-003028 ID - Cohen2013 ER - TY - JOUR AU - Juday, T. AU - Gupta, S. AU - Grimm, K. AU - Wagner, S. AU - Kim, E. PY - 2011 DA - 2011// TI - Factors associated with complete adherence to HIV combination antiretroviral therapy JO - HIV Clin Trials VL - 12 UR - https://doi.org/10.1310/hct1202-71 DO - 10.1310/hct1202-71 ID - Juday2011 ER -